510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2061-2016Class II

*** 1) Product labeled in part: 19734-28; LIFESHIELD; LIFESHIELD LATEX-FREE PLUM SET, MICRODRIP,PP...

Abbott Medical / initiated 2013-09-09 / Terminated / root cause: design

Hospira Inc. began a recall of *** 1) Product labeled in part: 19734-28; LIFESHIELD; LIFESHIELD LATEX-FREE PLUM SET, MICRODRIP,PP SOLUSET,FILTER, 3 CLAVE PORTS, OPTION-LOK, NON-DEHP; NOMINAL... on . FDA classified it as Class II and gives the reason as "Intravenous fluid may leak at the CLAVE secondary port of Hospira PlumSet IV administration sets". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-2061-2016
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Abbott Medical
Product
*** 1) Product labeled in part: 19734-28; LIFESHIELD; LIFESHIELD LATEX-FREE PLUM SET, MICRODRIP,PP SOLUSET,FILTER, 3 CLAVE PORTS, OPTION-LOK, NON-DEHP; NOMINAL LENGTH: 124 IN (315 IN); PRIMING VOLUME: 14 ML; *** 2) Product labeled in part: 19732-28; LIFESHIELD; LIFESHIELD LATEX-FREE PLUM SET,MICRODRIP,PP CHECK VALVE AND CLAVE OPTION-LOK, NON-DEHP; NOMINAL LENGTH:104 IN (264 CM); PRIMING VOLUME: 13 ML; Product Usage: The CLAVE of the secondary port is used as an easy secondary access that allows concurrent and piggyback mode in infusion. It is normally used with a syringe or a secondary IV infusion set.
Product code
FPA Set, Administration, Intravascular
Reason for recall
Intravenous fluid may leak at the CLAVE secondary port of Hospira PlumSet IV administration sets.
Root cause tag
design
FDA root cause
Device Design
Action
Hospira sent an URGENT MEDICAL DEVICE CORECTION letters dated September 9, 2013 to customers. The letter identified the affected product, problem and actions to be taken. the letter included additional instructions on the proper handling/use of the CLAVE devices. The letters request that all incidents of separation or breakage of CLAVE from the secondary port of the cassette be reported to Hospira by calling 1-800-441-410 (Monday - Friday, 8:00 AM - 5:00 PM CST) or by e-mail at [email protected]. Customers are further requested to complete and return a response form included wih the URGENT MEDICAL DEVICE CORRECTION letter and to notify any customers of this advisory. Hospira will also be supplementing the instructions for CLAVE use as an interim measure until a new method for bonding the CLAVE to the secondary port of the Plum cassettes can be devised and implemented.
Quantity in commerce
3,920,932 units in total
Distribution
US (Nationwide) Distribution
Product codes and lots
***** US DISTRIBUTION *****  *** 1) List Number: 19734-04-28; Lot Number:  133265H;   ***** CANADA DISTRIBUTION *****   *** 1) List Number: 19732-04-28; Lot Numbers:  114405H , 143545H , 170385H , 170425H , 170395H , 210225H , 201655H , 260535H , 291595H

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2061-2016
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2058-2016Class IITerminatedVoluntary: Firm initiated
Z-2059-2016Class IITerminatedVoluntary: Firm initiated
Z-2060-2016Class IITerminatedVoluntary: Firm initiated
Z-2061-2016Class IITerminatedVoluntary: Firm initiated
Z-2062-2016Class IITerminatedVoluntary: Firm initiated